Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
- Resource Type
- Article
- Source
- The Lancet Haematology; March 2020, Vol. 7 Issue: 3 pe196-e208, 13p
- Subject
- Language
- ISSN
- 23523026